A Pilot Study of Alemtuzumab (Campath[R]) in Patients With Myelodysplastic Syndrome

Sponsor and Collaborators     
National Heart, Lung, and Blood Institute (NHLBI)
National Institutes of Health Clinical Center (CC)

Contact    
Barbara Weinstein, R.N.     
(301) 594-4180     
[email protected]


Continue Reading

Investigator
National Heart, Lung, and Blood Institute (NHLBI)

ClinicalTrials.gov Identifier
NCT00217594